Global ConSeptS – Consultancy
Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards
Press Releases | September 24, 2025 | Inizio
Inizio has been named a finalist in six categories at the 2025 PM360 Trailblazer Awards, recognizing its teams’ excellence in AI, data analytics, education, patient engagement, and industry partnership across...
Inizio leaders featured in Forbes’ ‘Voices of Oncology’ to drive innovation in cancer care
Press Releases | September 24, 2025 | Inizio
Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.
Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities
Press Releases | September 22, 2025 | Medscape Education
Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...
CMI Media Group and Compas Earn 2025 Great Place To Work Certification
Press Releases | September 19, 2025 | CMI Media Group
PHILADELPHIA, PA – Strategic media healthcare agencies CMI Media Group & Compas, a WPP company (NYSE: WPP), are proud to be Certified™ by Great Place To Work® for the third year in...
solli – CMI’s International Man of Media
Press Releases | September 19, 2025 | CMI Media Group
Matt Durham, VP, Global, anticipated pharma’s global media boom. Now he’s leading CMI Media Group’s push to broaden its market coverage. This new profile article focusing on Global VP Matt...
PharmiWeb – Why Pharmaceutical Brands Must Act On Digital Trends Now
Press Releases | September 19, 2025 | CMI Media Group
The ASCO Conference has a global impact; a new PharmiWeb byline by Calum Griffin, Senior Global Engagement Planner inspired by the conference shares that the pharma marketing landscape has radically...
Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App
Press Releases | September 18, 2025 | Genetic Digital
Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.
AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation
Press Releases | September 17, 2025 | Innovative Trials
Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK
Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences
Press Releases | September 16, 2025 | Lucid Group Communications Limited
Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...
Streamlining European expansion for cell and gene therapies
White Papers and Resources | September 16, 2025 | Uniphar
Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...